David Sidransky
Impact in
- Otorhinolaryngology top 0.02%
- Head and Neck Cancer Studies
- Cancer Research top 0.01%
- Cancer Genomics and Diagnostics
Papers in
-
- Epigenetics and DNA Methylation 131
- RNA modifications and cancer 98
- Cancer-related gene regulation 71
- Mitochondrial Function and Pathology 35
- Oncology 161
- Cancer-related Molecular Pathways 98
- Co-authors
- Bert Vogelstein (10 shared papers)Curtis C. Harris (2 shared papers)Monica Hollstein (2 shared papers)Wayne M. Koch (90 shared papers)James G. Herman (19 shared papers)Joseph A. Califano (106 shared papers)William H. Westra (45 shared papers)Mohammad Obaidul Hoque (85 shared papers)
- Journals
- Cancer Research (42 papers)Clinical Cancer Research (32 papers)International Journal of Cancer (32 papers)PLoS ONE (20 papers)Oncogene (19 papers)
- Partner nations
- United StatesIndiaItaly
In The Last Decade
David Sidransky
568 papers receiving 64.6k citations
David Sidransky's Hit Papers
Peers
Comparison fields: 5 of 185
- Otorhinolaryngology 4.5k
- Cancer Research 13.9k
- Oncology 21.0k
- Pathology and Forensic Medicine 9.0k
- Molecular Biology 34.6k
Countries citing papers authored by David Sidransky
This map shows the geographic impact of David Sidransky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sidransky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sidransky more than expected).
Fields of papers citing papers by David Sidransky
This network shows the impact of papers produced by David Sidransky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sidransky. The network helps show where David Sidransky may publish in the future.
Co-authors
The 25 scholars most cited alongside David Sidransky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 576 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | p53 Mutations in Human Cancers Hit paper breakdown → | 1991 | 6725 |
| 2 | A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Hit paper breakdown → | 1998 | 3347 |
| 3 | 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers Hit paper breakdown → | 1995 | 1663 |
| 4 | Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Hit paper breakdown → | 1995 | 1152 |
| 5 | Genetic progression model for head and neck cancer: implications for field cancerization. Hit paper breakdown → | 1996 | 1061 |
| 6 | Head and Neck Cancer Hit paper breakdown → | 2001 | 1047 |
| 7 | Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer Hit paper breakdown → | 2006 | 861 |
| 8 | Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Hit paper breakdown → | 1999 | 770 |
| 9 | Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples Hit paper breakdown → | 1991 | 731 |
| 10 | Facile Detection of Mitochondrial DNA Mutations in Tumors and Bodily Fluids Hit paper breakdown → | 2000 | 690 |
| 11 | Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma Hit paper breakdown → | 2003 | 669 |
| 12 | TP53Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck Hit paper breakdown → | 2007 | 594 |
| 13 | Molecular Assessment of Histopathological Staging in Squamous-Cell Carcinoma of the Head and Neck Hit paper breakdown → | 1995 | 580 |
| 14 | Clonal expansion of p53 mutant cells is associated with brain tumour progression Hit paper breakdown → | 1992 | 577 |
| 15 | DPC4 gene in various tumor types. Hit paper breakdown → | 1996 | 568 |
| 16 | Role of the p16 tumor suppressor gene in cancer. Hit paper breakdown → | 1998 | 567 |
| 17 | Identification of ras Oncogene Mutations in the Stool of Patients with Curable Colorectal Tumors Hit paper breakdown → | 1992 | 556 |
| 18 | Microsatellite alterations in serum DNA of head and neck cancer patients Hit paper breakdown → | 1996 | 554 |
| 19 | Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Hit paper breakdown → | 1997 | 552 |
| 20 | Emerging molecular markers of cancer Hit paper breakdown → | 2002 | 525 |
About David Sidransky
David Sidransky is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Surgery, having authored 576 papers that have together received 65.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (131 papers), Cancer-related Molecular Pathways (98 papers), RNA modifications and cancer (98 papers), Cancer Genomics and Diagnostics (89 papers), Cancer-related gene regulation (71 papers), Genetic factors in colorectal cancer (70 papers), Head and Neck Cancer Studies (39 papers) and Mitochondrial Function and Pathology (35 papers). The work is most often cited by research in Otorhinolaryngology (4.5k citations), Cancer Research (13.9k citations), Oncology (21.0k citations), Pathology and Forensic Medicine (9.0k citations) and Molecular Biology (34.6k citations). David Sidransky has collaborated with scholars based in United States, India and Italy. Frequent co-authors include Bert Vogelstein, Curtis C. Harris, Monica Hollstein, Wayne M. Koch, James G. Herman, Joseph A. Califano, William H. Westra, Mohammad Obaidul Hoque, Stephen B. Baylin and Jin Jen. Their work appears in journals such as Cancer Research, Clinical Cancer Research, International Journal of Cancer, PLoS ONE and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.